Multiple cancer treatments, such as regimens that include anthracyclines and molecular targeted therapies, can cause cardiotoxicities. Patients who are at high risk for these dangerous adverse events (AEs) need to be identified and managed appropriately by educating everyone involved in the patients care and establishing collaboration between medical oncologists and cardiologists.
During the 2020 Association of Community Cancer Centers (ACCC) Virtual National Oncology Conference, a cardio-oncologist and nurse navigator explained the importance of identifying cardiotoxicities in patients with cancer and how to implement a program to help these patients have improved care coordination and experience through employing a nurse navigator.1
We have a population thats surviving their initial insult, whether that be cancer or heart disease, but then may subsequently develop, over the course of the next 10 to 15 years, the other comorbidity, Vijay U. Rao, MD, PhD, director of the Franciscan Health Cardio-Oncology Clinic and codirector of the Heart Failure Program and Anticoagulation Clinic at Franciscan Health, said in his presentation.
Both patients with breast cancer and patients with hematologic cancers, among a few others, are exposed to anthracycline chemotherapy. Patients who survive their cancer can experience the AEs that come with this type of therapy even years later. In some, there have been cases of irreversible heart dysfunction and heart failure, and for the worst-case scenarios, patients could not be managed medically and required heart transplantation, according to Rao.
Additionally, anti-angiogenic agents, such as VEGF-targeting regimens, can cause cardiotoxicity such as acute coronary syndrome, hypertension, heart failure, and left ventricle systolic dysfunction. Signal transduction inhibitors that target the HER family can cause QT prolongation, as well as heart failure and left ventricle systolic dysfunction.
To identify these cardiotoxicities in patients, physicians need the patients history and physical exam, as well as an ECG and imaging including a multigated acquisition scan, echocardiogram, and cardiac MRI, which is the gold standard for assessment of left ventricular function, according to Rao. Biomarkers also need to be looked at such as troponin and b-type natriuretic peptide.
Predictors of cardiotoxicity include female gender; being under the age of 15 or over the age of 65; pre-existing cardiovascular disease; hypertension; receiving mediastinal radiation; and the type, rate, and dose of anthracycline administration.2,3 Rao said that the radiation predictor is important because radiation is given to patients who also receive anthracyclines for multiple malignancies including breast cancer and certain lymphomas.
To treat patients that experience cardiotoxicity, there are therapies such as ace-inhibitors, beta-blockers like carvedilol (Coreg) and nebivolol (Bystolic), statinswhich lower cholesteroland dexrazoxane (Zinecard). The sooner patients at high risk for cardiotoxicities are identified, the sooner they can receive the proper monitoring and treatment they need to lessen or avoid cardiotoxicity altogether.
A cardio-oncology program was initiated at Franciscan Health to identify and patients these patients who were at risk for cardiotoxicities. A main goal of the program was to be proactive through the early recognition and treatment of cardiotoxicities by cardiovascular risk assessment and prevention. The program would identify those at risk, triage cardiovascular complications, and set up survivorship plans for the patients.
After the Franciscan Health Cardio-Oncology Program was started, Rao realized it was important to explain to oncologists that the goal of the program was to continue therapy safely and be able to have better patient outcomes overall, not to stop chemotherapy altogether. To do that in the most efficient way, Raos program developed workflows that benefitted inter-departmental collaboration, so that they did not slow the process down for patients. They were able to get patients tested and seen for consultation within their target time of 7 days.
Through developing this process, the Franciscan Health Cardio-Oncology Program saw that they needed someone that was living in the oncology world who could bridge the gap between cardiology and oncology to identify those patients, to relate to those patients, to have the ear of the oncologist, and tell them the patient needs to be seen by the cardio-oncologist for help, Rao said.
A nurse navigator was suggested to bridge the gap and provide cardio-oncology surveillance as an ongoing task. Through testing and chart reviews of patients, subsequent identification of patients who are at risk with the cardiac risk assessment tools, and referrals of those patients to the cardio-oncologist based on their results, the nurse navigators can successfully help patients reduce their cardiotoxicity risk and minimize interruption of oncology treatment.
Kerry Skurka, RN, BSN, a cardio-oncology nurse navigator at Franciscan Health, discussed where they started when creating this program and why a nurse navigator was needed. After starting as a nurse navigator and working with both cardiologists and oncologists, she realized she had to be the connection for them and for the patients.
She described the first step to implementation of such a program as assessing the current practiceand meeting the providers where they are. Then a foundational education of guidelines, clinical literature, and research can be introduced. She recommended options including the American College of Cardiology, the American Society of Clinical Oncology, and the National Comprehensive Cancer Network guidelines. From there, processes and workflows can be established for the identification of patients using existing risk assessment tools.
Skurka also suggested that these programs should start small, because they grow quickly. These programs are highly dependent on a cohesive multidisciplinary team that collaborates and communicates consistently. Establishing a sub-committee of clinical staff who take care of program development as well as establishing a steering committee to inform administration and other key stakeholders of how that development is going is vital.
You have to look at processes and workflows, and you have to work on both sides of the fence. Both the oncology office and the cardiology office, Skurka said.
The workflow used at Franciscan Health grouped patients with cancer under 3 categories: before treatment, during treatment, and post-treatment. Each of these patient statuses still required the patient to go through a cardiovascular review of the patients history, physical exam, imaging, and testing. Then the risks or complications identified by the assessment told whether that patient needed a cardio-oncology consult.
The goal of the oncologist is the best treatment [for patients] with the minimal amount of AEs, as close to guideline recommended, so they can get the best outcomes. The goal of our cardiologists was to assist them to meet that goal, Skurka said.
From a poster by Skurka, Rao, and their colleagues, which was presented at the 68th Scientific Session of the American College of Cardiology,4 there were 259 patients referred to the cardio-oncology clinic between January 2017 and November 2018. There were also 625 patients receiving intravenous therapy at this time under the care of Skurka, including those who were referred, and 300 patients who received oral therapy in 2018 were navigated to the clinic.
The results of this analysis showed that the majority of patients were referred during treatment (84%) versus pre-chemotherapy (12%) and post-treatment (4%). The most common reasons for referral were decreased ejection fraction (25%) and blood pressure issues (24%). Of the common comorbidities and risk factors, the most common were hypertension (17%), hyperlipidemia (16%), and female gender (16%).
Right now, the Franciscan Health Cardio-Oncology Program averages 11 patients a week and has hired a second nurse navigator to focus on patients receiving oral treatments. From May 2018 to May 2020, there was a total of 444 patients who received oral antineoplastic treatment and 18% of referrals to cardio-oncology were from antineoplastic patients.
Some of the accomplishments of the program Skurka highlighted was the acquisition of an ECG machine, a biweekly clinic that will become weekly, and quarterly tumor board presentations. They also started blocking out 2 or 3 office visits for the cardiologist a week since patients need to be seen quickly. She said, you [have] to know the availability of the cardiologist.
Cardio-oncology works best in collaboration. It helps to decrease patients cardiovascular outcomes and increase their quality of life and survivorship. Having a program thats interdepartmental helps increase awareness and education among providers, administrators, and key stakeholders, including payers, Skurka concluded.
References:
1. Rao V, Skurka K. A nurse navigator led community-based cardio-oncology clinic. Slides presented at: the Association of Community Cancer Centers Virtual National Oncology Conference; September 14-18, 2020; Virtual
2. an Dalen EC, Michiels EMC, Caron HN, Kremer LCM. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev. 2010;2010(5):CD005006. doi:10.1002/14651858.CD005006.pub4
3. Ewer MS, Ewer SM. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Natl Rev Cardiol. 2010;7(10):564-575. doi:10.1038/nrcardio.2010.121
4. Skurka K, Page H, Daly R, et al. Foundational Role of Nurse Navigation in a Community-Based Cardio-Oncology Program: The Franciscan Health Indianapolis Experience. Presented at: 68th Scientific Session of the American College of Cardiology; March 16-18, 2019; New Orleans, LA.
See more here:
Bridging the Gap Between Oncology and Cardiology Takes a Nurse Navigator - Targeted Oncology
- Hypertension: Practice Essentials, Background, Pathophysiology - Medscape Reference - April 10th, 2018 [April 10th, 2018]
- High blood pressure (hypertension) - Symptoms and causes ... - May 18th, 2018 [May 18th, 2018]
- 10 Causes of Hypertension - A Diet High In Salt Content - June 21st, 2018 [June 21st, 2018]
- Homeopathy Hypertension Remedies | High Blood Pressure ... - July 5th, 2018 [July 5th, 2018]
- European Society of Hypertension - July 7th, 2018 [July 7th, 2018]
- List of High Blood Pressure (Hypertension) Medications (259 ... - July 26th, 2018 [July 26th, 2018]
- Hypertension (High Blood Pressure) Charts, Symptoms, Diet ... - September 2nd, 2018 [September 2nd, 2018]
- Vitamin D and hypertension - September 8th, 2018 [September 8th, 2018]
- 2014 Guideline for Management of High Blood Pressure - September 29th, 2018 [September 29th, 2018]
- Essential hypertension - Wikipedia - September 30th, 2018 [September 30th, 2018]
- Hypertension Treatment & Drugs | Hypertension Causes ... - September 30th, 2018 [September 30th, 2018]
- Hypertension (High Blood Pressure) - October 13th, 2018 [October 13th, 2018]
- Hypotension - Wikipedia - October 30th, 2018 [October 30th, 2018]
- Hypertension | pathology | Britannica.com - October 30th, 2018 [October 30th, 2018]
- Hypertension | Cornell University College of Veterinary Medicine - November 10th, 2018 [November 10th, 2018]
- 2014 Guideline for Management of High Blood Pressure - JAMA - November 18th, 2018 [November 18th, 2018]
- Pharmacologic Treatment of Hypertension in Adults | Annals ... - November 18th, 2018 [November 18th, 2018]
- 10 Causes of Hypertension - High In Salt Consumption - November 29th, 2018 [November 29th, 2018]
- High blood pressure (hypertension) - Diagnosis and treatment ... - November 29th, 2018 [November 29th, 2018]
- High Blood Pressure Symptoms - Hypertension Symptoms - December 9th, 2018 [December 9th, 2018]
- Hypertension - Medscape Reference - December 21st, 2018 [December 21st, 2018]
- Hypertension - Lab Tests Online - December 21st, 2018 [December 21st, 2018]
- High Blood Pressure (Hypertension): Symptoms ... - OnHealth - December 21st, 2018 [December 21st, 2018]
- High Blood Pressure | Hypertension | MedlinePlus - December 27th, 2018 [December 27th, 2018]
- Hypertension - Wikipedia - December 27th, 2018 [December 27th, 2018]
- Hypertension: Causes and Risk Factors - verywellhealth.com - January 1st, 2019 [January 1st, 2019]
- Hypertension - Genetics Home Reference - NIH - January 20th, 2019 [January 20th, 2019]
- Hypertension: Nursing Care Management and Study Guide - April 7th, 2019 [April 7th, 2019]
- High blood pressure (hypertension) Disease Reference Guide ... - April 7th, 2019 [April 7th, 2019]
- Pulmonary hypertension - Symptoms and causes - Mayo Clinic - September 14th, 2019 [September 14th, 2019]
- Incident Hypertension Associated With Continuous NSAID Use in Ankylosing Spondylitis - Rheumatology Advisor - October 12th, 2019 [October 12th, 2019]
- The innovative new ways scientists are tackling high blood pressure - Noted - October 12th, 2019 [October 12th, 2019]
- If You Have High Blood Pressure, You May Be at Higher Risk for This Cancer - msnNOW - October 12th, 2019 [October 12th, 2019]
- MODERATO II Study: Cardiac Neuromodulation Significantly Reduces Systolic Blood Pressure - Diagnostic and Interventional Cardiology - October 12th, 2019 [October 12th, 2019]
- Kidney-heart connection is focus of upcoming HealthyLife seminar - Times Union - October 12th, 2019 [October 12th, 2019]
- High blood pressure: Six foods proven to lower your reading - Express - October 14th, 2019 [October 14th, 2019]
- Sepetaprost Effective and Safe in Glaucoma, Ocular Hypertension - Monthly Prescribing Reference - October 14th, 2019 [October 14th, 2019]
- India, Stressed: More than Half of Commuters in Metro Cities Likely to Commit Road Rage - News18 - October 17th, 2019 [October 17th, 2019]
- University College London Awarded 1M to Advance Heart, PH Research Using Computational Biology - Pulmonary Hypertension News - October 17th, 2019 [October 17th, 2019]
- One in 10 children on the verge of heart attack risk - The New Daily - October 17th, 2019 [October 17th, 2019]
- Healthy living: Salt and hypertension - Forbes India - October 17th, 2019 [October 17th, 2019]
- The global blood pressure (BP) monitoring devices market size is expected to reach USD 2.47 billion by 2026 - GlobeNewswire - October 17th, 2019 [October 17th, 2019]
- Vitamin D Deficiency And Hypertension: Is There A Relation Between Low Levels Of Vitamin D And High Blood Pressure? - NDTV News - October 17th, 2019 [October 17th, 2019]
- Hypertension in Indians - Forbes India - October 17th, 2019 [October 17th, 2019]
- Health: Worrying rise of hypertension in Indians - Forbes India - October 17th, 2019 [October 17th, 2019]
- More than 1100 health care organizations earn BP-control honor - American Medical Association - October 17th, 2019 [October 17th, 2019]
- Medication Adherence In Patients With Arterial Hypertension: The Relat | PPA - Dove Medical Press - October 17th, 2019 [October 17th, 2019]
- High levels of stress increase hypertension risk in black individuals - Healio - October 17th, 2019 [October 17th, 2019]
- Dapagliflozin Receives FDA Approval for Reducing Heart Failure Hospitalization Risk - Endocrinology Advisor - October 23rd, 2019 [October 23rd, 2019]
- Death of Clay County inmate prompts change in housing for inmates with specific medical needs - FirstCoastNews.com WTLV-WJXX - October 23rd, 2019 [October 23rd, 2019]
- New OPSUMIT (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical and Functional Parameters in Patients with... - October 23rd, 2019 [October 23rd, 2019]
- High Blood Pressure: Why salt is considered a harbinger of hypertension? - PINKVILLA - October 23rd, 2019 [October 23rd, 2019]
- Chronic Stress in African-Americans Linked to Hypertension - TCTMD - October 23rd, 2019 [October 23rd, 2019]
- Why all the fuss around hypertension? - Firstpost - October 23rd, 2019 [October 23rd, 2019]
- Study explores why Caribbean adults have higher hypertension rates - Yale News - October 23rd, 2019 [October 23rd, 2019]
- Hypertension in adults: summary of updated NICE guidance - The BMJ - October 23rd, 2019 [October 23rd, 2019]
- Diabetes, blood pressure and cancer cases are rising rapidly in India - Times of India - November 2nd, 2019 [November 2nd, 2019]
- Is there a link between breastfeeding and diabetes - Medical News Bulletin - November 2nd, 2019 [November 2nd, 2019]
- High Blood Pressure: Lower hypertension by eating less of these food groups - PINKVILLA - November 2nd, 2019 [November 2nd, 2019]
- Chronic high blood pressure in pregnant women on the rise - MahoningMatters.com - November 2nd, 2019 [November 2nd, 2019]
- Unhealthy Lifestyle and Indian Ethnicity Tied to Hypertension - Forbes India - November 2nd, 2019 [November 2nd, 2019]
- Cardio Round-up: Walkability and CVD; Pollution and Stroke; and More - DocWire News - November 2nd, 2019 [November 2nd, 2019]
- Hypertension Tied to Over One-Third of Population-Attributable CVD Risk in U.S. Black Adults - DocWire News - November 2nd, 2019 [November 2nd, 2019]
- This Is What Makes Oats Idli An Ideal Breakfast For A High Blood Pressure Diet - NDTV Food - November 11th, 2019 [November 11th, 2019]
- Global Idiopathic Intracranial Hypertension Therapeutics Market 2019-2023 | Evolving Opportunities with AbbVie Inc. and Astellas Pharma Inc. |... - November 11th, 2019 [November 11th, 2019]
- Severe Hypertension Common in aHUS Patients and Soliris Effective at Treating Them, Study Finds - aHUS News - November 11th, 2019 [November 11th, 2019]
- Overhydration Is a Risk Factor for Post-Dialysis Hypertension - Renal and Urology News - November 11th, 2019 [November 11th, 2019]
- In AS, Hypertension Risk Linked to Continuous NSAID Use, Study Says - Ankylosing Spondylitis News - November 11th, 2019 [November 11th, 2019]
- Physicians, Patient Discuss Intentional Nonadherence in Hypertension Therapy - AJMC.com Managed Markets Network - November 11th, 2019 [November 11th, 2019]
- More than 50,000 suffer from diabetes, nearly a lakh from hypertension - The Indian Express - November 14th, 2019 [November 14th, 2019]
- Cause of John Witherspoons untimely death revealed - TheGrio - November 14th, 2019 [November 14th, 2019]
- This Hyderabad-based Start-up is Helping Corporates Improve the Health of their Employees - Entrepreneur - November 14th, 2019 [November 14th, 2019]
- ER visits jumped after valsartan blood pressure medication recall, study says - CBC.ca - November 14th, 2019 [November 14th, 2019]
- The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension - Science - November 14th, 2019 [November 14th, 2019]
- Health screenings given to raise awareness at West Philly barbershop - The Philadelphia Tribune - November 14th, 2019 [November 14th, 2019]
- Blood pressure monitoring must be a part of a diabetic's routine - Gulf News - November 14th, 2019 [November 14th, 2019]
- Early Warning Signs of CKD Going Unnoticed in Veterans, Especially Those With Hypertension - AJMC.com Managed Markets Network - November 14th, 2019 [November 14th, 2019]
- The Epidemic of Hypertension and Vulnerability of Indians - Forbes India - November 14th, 2019 [November 14th, 2019]
- Knowing the facts: Hypertension vis-a-vis Lifestyle - Forbes India - November 14th, 2019 [November 14th, 2019]
- Heart hormones that affect development of diabetes, hypertension differ in African Americans and whites - UAB News - November 14th, 2019 [November 14th, 2019]